期刊文献+

TRIF在Buerger’s病患者腰交感神经节中的表达及其意义 被引量:4

The expression and distribution of TRIF in the lumbar sympathetic ganglion neuron of Buerger's disease
下载PDF
导出
摘要 目的观察β干扰素Toll样受体结构域衔接蛋白(Toll/IL-1 receptor domain containing adaptor inducing IFN-β,TRIF)在Buerger’s病患者腰交感神经节中的表达,探讨TRIF在Buerger’s病发病中的作用机制。方法收集2012年8月至2013年5月我院行腰交感神经节切除术的Buerger’s病患者手术标本30例为Buerger’s病组,同期肝移植供体者腰交感神经节6例为对照组。应用免疫组化、反转录PCR(RT-PCR)技术及蛋白质印迹(Western blot)技术测定2组腰交感神经节中TRIF的表达水平并且比较组间差异。进一步采用激光共聚焦技术,检测TRIF在Buerger’s病患者神经元中的表达特点。结果 Buerger’s病患者腰交感神经节中TRIF的mRNA和蛋白表达水平明显高于对照组(P<0.01)。并且,在Buerger’s病患者腰交感神经节组织中,TRIF主要分布于神经细胞之中。结论 TRIF与Buerger’s病的发生和发展关系密切;Toll样受体信号通路激活可能是Buerger’s病发病的重要因素。 To observe the expression and distribution of Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) in the lumbar sympathectomy of Buerger's patients, resections of lumbar sympathetic ganglion from 30 patients with Buerger's disease were analyzed, with 6 cases of donors for hepatic transplantation as control group. The expression of TRIF was detected by immunohistochemistry, reverse transcription quantitative PCR (RT-PCR) and Western blot technology in Buerger's disease group and control group. In Buerger's disease group, the results of RT-PCR and Western blot indicated that the expression of TRIF was much higher than that of in control group (P〈 0.01). Immunohistochemistry and immunofluorescence staining images revealed that TFIF was mainly expressed and distributed in the nerve cells of lumbar sympathetic ganglia tissues. Our results indicated that the expression of TRIF is significant increased in lumbar sympathetic ganglion of 30 patients with Buerger's disease, and the activation of TLRs-TRIF may correlated with the occurrence and development of Buerger's disease.
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第4期314-318,共5页 Immunological Journal
基金 重庆市卫生局医学科研计划项目(2009-2-307)
关键词 Buerger’s病 TRIF 腰交感神经节 Buerger's disease TRIF Lumbar sympathetic ganglion
  • 相关文献

参考文献18

  • 1Joviliano EE, Dellalibera Joviliano R, Dalio M, et al, Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans-current practices[J], lnt J Angiol, 2009, 18(3): 119-125.
  • 2Lazarides MK, Georgiadis GS, Papas TT, et al. Diagnostic criteria and treatment of Buerger's disease: a review[J]. Int J Low Extrem Wounds, 2006, 5(2): 89-95.
  • 3Iwase S, Okamoto T, Mano T, et al. Skin sympathetic outflow in Buerger's disease[J]. Auton Neurosci, 2001, 87(2/3): 286-292.
  • 4Arkkila PE. Thromboangiitis obliterans (Buerger's disease)[J].Orphanet J Rare Dis, 2006, 1: 14.
  • 5Chen Z, Nakajima T, Inoue Y, et al. A single nucleotide polymorphism in the 3'-untranslated region of MyD88 gene is associated with Buerger disease but not with Takayasu arteritis in Japanese[J]. J Hum Genet, 2011, 56(7): 545-547.
  • 6Ketha SS, Cooper LT. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease) [J]. Ann NY Acad Sci, 2013, 1285(1): 15-25.
  • 7Szuba A, Cooke JP. Thromboangiitis obliterans. An update on Buerger's disease[J]. West J Med, 1998, 168(4): 255-260.
  • 8Singh K, Sood S. Autonomic functions in Buerger disease[J]. Indian Physiol Pharmacol, 2001, 45(4): 470-474.
  • 9Roncon Albuquerque R, Serrao P, Vale Pereira R, et al. Plasma catecholamines in Buerger's disease: effects of cigarette smoking and surgical sympathectomy [J]. Eur J Vasc Endovasc Surg, 2002, 24(4): 338-343.
  • 10Paraskevas KI, Trigka AA, Samara M. Successful intravenous regional sympathetic blockade (Bier's Block) with guanethidine and lidocaine in a patient with advanced Buerger's Disease -a case report[J]. Angiology, 2005, 56(4): 493-496.

二级参考文献28

  • 1Sato S,Sanjo H,Takeda K,et al.Essential function of thekinase TAK1 in innate and adaptive immune responses[J].Nat Immunol,2005,6(11):1087-1095.
  • 2Yamamoto M,Okamoto T,Takeda K,et al.Key functionfor the Ubc13 E2 ubiquitin-conjugating enzyme in immunereceptor signaling[J].Nat Immunol,2006,7(9):962-970.
  • 3Huang Q,Yang J,Lin Y,et al.Differential regulation ofinterleukin 1 receptor and Toll-like receptor signaling byMEKK3[J].Nat Immunol,2004,5(1):98-103.
  • 4Hu X,Chen J,Wang L,et al.Crosstalk among Jak-STAT,Toll-like receptor,and ITAM-dependent pathways inmacrophage activation[J].J Leukoc Biol,2007,82(2):237-243.
  • 5Uematsu S,Akira S.Tol l-like receptors and innateimmunity[J].J Mol Med,2006,84(9):712-725.
  • 6Yu JE,Knight AK,Radigan L,et al.Toll-like receptor 7and 9 defects in common variable immunodeficiency[J].JAllergy Clin Immunol,2009,124(2):349-356.
  • 7Di Domizio J,Blum A,Gallagher Gambarelli M,et al.TLR7 stimulation in human plasmacytoid dendritic cellsleads to the induction of early IFN-inducible genes in theabsence of type I IFN[J].Blood,2009,114(9):1794-1802.
  • 8Konno H,Yamamoto T,Yamazaki K,et al.TRAF6establishes innate immune responses by activation NF-kappaB and IRF7 upon sensing cytosolic viral RNA andDNA[J].PloS One,2009,4(5):e5674.
  • 9Sekine Y.Novel adaptor protein,STAP-2 functions as asignal modulator in immune syste m[J].Yakugaku Zasshi,2010,130(6):769-775.
  • 10Mendoza Barbera E,Corral Rodriguez MA,SoaresSchanoski A,et al.Contribution of globular death domainsand unstructured linkers to MyD88.IRAK-4 heterodimerformation:an explanation for the antagonistic activity ofMyD88s[J].Biochem Biophys Res Commun,2009,380(1):183-187.

共引文献78

同被引文献7

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部